Microbix - President and CEO, Cameron L. Groome.

" Microbix (TSX:MBX) receives $4.7M order

Microbix (MBX) has received a binding C$4.7M follow-on order for its viral transport medium.
Appili Therapeutics - CEO, Armand Balboni.

" Appili Therapeutics (TSX:APLI) announces $7 million overnight offering

Appili Therapeutics (APLI) has announced a C$7 million overnight marketed offering of equity securities.

" PharmaDrug (CSE:PHRX) announces meeting with FDA

PharmaDrug (PHRX) has been granted a pre-investigational new drug meeting with the FDA for its COVID-19 treatment.

" ScreenPro (CSE:SCRN) providing COVID-19 testing at TIFF

ScreenPro (SCRN) is providing COVID-19 testing services at this year’s Toronto International Film Festival.
BetterLife Pharma - CEO, Ahmad Doroudian.

" BetterLife Pharma (CSE:BETR) initiates preclinical study against Delta variant

BetterLife Pharma (BETR) has initiated a preclinical study of AP-003 (rhIFNa2b) against the Delta variant of SARS-CoV-2.

" Relay (CSE:RELA) and Fio report successful COVID-19 testing at the 2021 National Bank Open presented by Rogers

Relay Medical (RELA) and Fio are pleased to report the successful deployment of its Fionet Platform at the 2021 National Bank Open Tennis
Sixth Wave Innovations - President and CEO, Dr. Jon Gluckman (left).

" Sixth Wave Innovations’ (CSE:SIXW) AMIPs technology detects Delta variant

Sixth Wave’s (SIXW) accelerated molecular imprinted polymers (AMIPs) technology has detected the Delta variant of SARS-CoV-2.
BetterLife Pharma - CEO, Ahmad Doroudian.

" BetterLife’s (CSE:BETR) AP-003 shown to be effective against COVID-19 variants

BetterLife’s (BETR) AP-003 has shown similar efficacy against COVID-19 variants in a preclinical study.

" ScreenPro (CSE:SCRN) launches concierge medical service

ScreenPro (SCRN) will now offer concierge medical services providing home visit care beginning July 12.

" ScreenPro Security (CSE:SCRN) expands into Montreal

ScreenPro (SCRN) has expanded its operations into Montreal due to client demand.
Revive Therapeutics - CEO, Michael Frank

" Revive Therapeutics (CSE:RVV) partners with Supriya Lifescience to treat COVID-19 in India

Revive Therapeutics (RVV) has joined forces with Supriya to pursue Emergency Use Authorization for Bucillamine to treat COVID-19 in India.